Stay updated on Talquetamab Dose Escalation in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.

Latest updates to the Talquetamab Dose Escalation in Myeloma Clinical Trial page
- Check7 days agoChange DetectedAdded a new 2026-02-13 entry for Study Status in the record history. A deletion dated 2026-01-16 is also shown.SummaryDifference0.2%

- Check14 days agoChange DetectedAdded a new revision entry (v3.4.2) to the page history, and the prior funding-lapse notice and v3.4.1 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedThe only visible changes are a site-wide funding notice and revision updates (v3.4.1 replacing v3.4.0), which do not affect trial data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedGlossary visibility has been added, and color-coded highlights now distinguish additions (green) from deletions (red) on the record history. The latest revision is labeled v3.4.0, and the formatting of the 'No FEAR Act data' entry has been updated.SummaryDifference0.4%

- Check35 days agoChange DetectedA new version entry dated 2026-01-16 adds a 'Study Status' field to the record with revision v3.3.4, and the previous entry dated 2025-12-05 (v3.3.3) was removed.SummaryDifference0.2%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 to the record history and removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Talquetamab Dose Escalation in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.